Neogen (NASDAQ:NEOG) Reaches New 52-Week Low at $21.08

Neogen Co. (NASDAQ:NEOGGet Rating)’s stock price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $21.08 and last traded at $21.24, with a volume of 202635 shares traded. The stock had previously closed at $22.18.

Wall Street Analyst Weigh In

Separately, Piper Sandler started coverage on shares of Neogen in a research note on Monday, July 11th. They issued a “neutral” rating and a $25.00 price target for the company.

Neogen Stock Down 0.6 %

The firm has a market cap of $2.31 billion, a P/E ratio of 47.60 and a beta of 0.58. The firm’s 50-day moving average price is $23.55 and its 200 day moving average price is $29.06.

Insider Buying and Selling at Neogen

In related news, Director James P. Tobin acquired 2,000 shares of the business’s stock in a transaction on Wednesday, July 27th. The shares were purchased at an average price of $22.98 per share, for a total transaction of $45,960.00. Following the acquisition, the director now owns 14,000 shares in the company, valued at $321,720. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Neogen news, Director James P. Tobin bought 2,000 shares of the company’s stock in a transaction dated Wednesday, July 27th. The shares were bought at an average price of $22.98 per share, for a total transaction of $45,960.00. Following the acquisition, the director now directly owns 14,000 shares of the company’s stock, valued at $321,720. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronald D. Green bought 1,500 shares of the company’s stock in a transaction dated Tuesday, August 2nd. The stock was acquired at an average price of $22.50 per share, for a total transaction of $33,750.00. Following the acquisition, the director now directly owns 10,694 shares in the company, valued at $240,615. The disclosure for this purchase can be found here. In the last three months, insiders acquired 21,000 shares of company stock valued at $483,435. 0.52% of the stock is owned by insiders.

Hedge Funds Weigh In On Neogen

A number of hedge funds have recently added to or reduced their stakes in the company. Profund Advisors LLC boosted its position in Neogen by 2.9% during the fourth quarter. Profund Advisors LLC now owns 9,851 shares of the company’s stock worth $447,000 after purchasing an additional 282 shares during the period. Pacer Advisors Inc. boosted its position in Neogen by 2.6% during the fourth quarter. Pacer Advisors Inc. now owns 15,296 shares of the company’s stock worth $695,000 after purchasing an additional 390 shares during the period. Stephens Inc. AR boosted its position in Neogen by 3.9% during the fourth quarter. Stephens Inc. AR now owns 10,685 shares of the company’s stock worth $485,000 after purchasing an additional 401 shares during the period. Patriot Financial Group Insurance Agency LLC boosted its position in shares of Neogen by 87.5% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 913 shares of the company’s stock valued at $28,000 after acquiring an additional 426 shares during the period. Finally, Crossmark Global Holdings Inc. boosted its position in shares of Neogen by 4.4% in the first quarter. Crossmark Global Holdings Inc. now owns 10,284 shares of the company’s stock valued at $317,000 after acquiring an additional 430 shares during the period. Institutional investors and hedge funds own 92.91% of the company’s stock.

Neogen Company Profile

(Get Rating)

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Recommended Stories

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.